Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is O  [Clear All Filters]
2023
Verma R, Chen X, Xin D, Luo Z, Ogurek S, Xin M, Rao R, Berry K, Q Lu R. Olig1/2-expressing intermediate lineage progenitors are predisposed to PTEN/p53-loss-induced gliomagenesis and harbor specific therapeutic vulnerabilities. Cancer Res. 2023.
Xu J, Wang R, Luo W, Mao X, Gao H, Feng X, Chen G, Yang Z, Deng W, Nie Y. Oligodendrocyte progenitor cell-specific delivery of lipid nanoparticles loaded with Olig2 synthetically modified messenger RNA for ischemic stroke therapy. Acta Biomater. 2023.
Pan L, Trimarco A, Zhang AJ, Fujimori K, Urade Y, Sun LO, Taveggia C, Zhang Y. Oligodendrocyte-lineage cell exocytosis and L-type prostaglandin D synthase promote oligodendrocyte development and myelination. Elife. 2023;12.
Zhang N, Sullivan MJ, Curtis BR, Newman PJ. O-linked sialic acid residues on platelet membrane glycoprotein (GP) IIb mask the human HPA-9b alloepitope. Blood. 2023.
Yang H, Song S, Li J, Li Y, Feng J, Sun Q, Qiu X, Chen Z, Bai X, Liu X, et al. Omentin-1 drives cardiomyocyte cell cycle arrest and metabolic maturation by interacting with BMP7. Cell Mol Life Sci. 2023;80(7):186.
Li Z, Fang X, Wang S. Omentum provides a special cell microenvironment for ovarian cancer. Cancer Rep (Hoboken). 2023:e1858.
Notopoulou S, Gkekas I, Petrakis S. Omics Analyses in a Neural Stem Cell Model of Familial Parkinson's Disease. Adv Exp Med Biol. 2023;1423:149-160.
Nava AA, Arboleda VA. The omics era: a nexus of untapped potential for Mendelian chromatinopathies. Hum Genet. 2023.
Ravagnani FG, Valerio HP, Maués JHS, de Oliveira AN, Puga RD, Griesi-Oliveira K, Picosse FR, Ferraz HB, Catharino RR, Ronsein GE, et al. Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients. Parkinsonism Relat Disord. 2023;116:105847.
Ju L-F, Xu H-J, Yang Y-G, Yang Y. Omics Views of Mechanisms for Cell Fate Determination in Early Mammalian Development. Genomics Proteomics Bioinformatics. 2023.
Heo Y-A. Omidubicel: First Approval. Mol Diagn Ther. 2023.
Huang X, Liang F, Huang B, Luo H, Shi J, Wang L, Peng J, Chen Y. On-chip real-time impedance monitoring of hiPSC-derived and artificial basement membrane-supported endothelium. Biosens Bioelectron. 2023;235:115324.
Pichavaram P, Jablonowski CM, Fang J, Fleming AM, Gil HJin, Boghossian AS, Rees MG, Ronan MM, Roth JA, Morton CL, et al. Oncogenic cells of renal embryonic lineage sensitive to the small molecule inhibitor QC6352 display depletion of KDM4 levels and disruption of ribosome biogenesis. Mol Cancer Ther. 2023.
Ou Z-Y, Wang K, Shen W-W, Deng G, Xu Y-Y, Wang L-F, Zai Z-Y, Ling Y-A, Zhang T, Peng X-Q, et al. Oncogenic FLT3 internal tandem duplication activates E2F1 to regulate purine metabolism in acute myeloid leukaemia. Biochem Pharmacol. 2023:115458.
Fischer AD, Veronese-Paniagua DA, Swaminathan S, Kashima H, Rubin DC, Madison BB. The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2023.
Desai R, Huang L, Gonzalez RS, Muthuswamy SK. Oncogenic GNAS uses PKA-dependent and independent mechanisms to induce cell proliferation in human pancreatic ductal and acinar organoids. Mol Cancer Res. 2023.
Capik O, Gundogdu B, Tatar A, Sahin A, Chen F, Creighton CJ, Karatas OFaruk. Oncogenic miR-1825 promotes head and neck carcinogenesis via targeting FREM1. J Cell Biochem. 2023.
Anon. Oncogenic Mutations Control Stem Cell Polarization in Colorectal Cancer. Cancer Discov. 2023:OF1.
Insco ML, Abraham BJ, Dubbury SJ, Kaltheuner IH, Dust S, Wu C, Chen KY, Liu D, Bellaousov S, Cox AM, et al. Oncogenic mutations impede nuclear RNA surveillance. Science. 2023;380(6642):eabn7625.
Qin X, Rodriguez FCardoso, Sufi J, Vlckova P, Claus J, Tape CJ. An oncogenic phenoscape of colonic stem cell polarization. Cell. 2023;186(25):5554-5568.e18.
An N, Khan S, Imgruet MK, Jueng L, Gurbuxani S, McNerney ME. Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells. Oncogene. 2023.
Sunaga N, Kaira K, Shimizu K, Tanaka I, Miura Y, Nakazawa S, Ohtaki Y, Kawabata-Iwakawa R, Sato M, Girard L, et al. The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancer. Thorac Cancer. 2023.
Luo J, Zou H, Guo Y, Tong T, Chen Y, Xiao Y, Pan Y, Li P. The oncogenic roles and clinical implications of YAP/TAZ in breast cancer. Br J Cancer. 2023.
Sell T, Klotz C, Fischer MM, Astaburuaga-García R, Krug S, Drost J, Clevers H, Sers C, Morkel M, Blüthgen N. Oncogenic signaling is coupled to colorectal cancer cell differentiation state. J Cell Biol. 2023;222(6).
Duffau H. Oncological and functional neurosurgery: Perspectives for the decade regarding diffuse gliomas. Rev Neurol (Paris). 2023.

Pages